News
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
Primary care physicians and the state Senate’s health care point person are questioning a proposed partnership between Mass ...
The Gilead HIV prevention shot , called Yevtugo, is highly effective, but its list price is $28, 218 a year in the U.S.
CVS Health is not entitled to coverage from insurers, including AIG and Chubb , against thousands of lawsuits over its role ...
Ongoing activity at a former CVS location at 1803 N. Illinois St. in Swansea has become more noticeable as the building’s ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
A CVS store in Warren County will be closing its doors for good next month. The CVS Pharmacy at 150 South Main Street in ...
CVS Health (CVS) stock in focus as its pharmacy benefit manager CVS Caremark faces $289.9M in damages and penalties for ...
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...
Narrative CVs offer researchers the opportunity to present their careers through their own stories, focusing on achievements, ...
5h
Zacks Investment Research on MSNGILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
Shares of Gilead Sciences, Inc. (GILD) tumbled 2.2% on Aug. 21, after pharmacy benefit manager CVS Health (CVS) decided not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results